Our Healthcare News

Restoration Robotics and Venus Concept Announce Merger to Create a Leading Global Medical Aesthetics Company

SAN JOSE, California and TORONTO, (GLOBE NEWSWIRE)—Restoration Robotics, Inc. (“Restoration Robotics”) (HAIR), a global leader in robotic hair restoration, and Venus Concept Ltd. (“Venus Concept”),…  

Mar 15 2019

Patricia Altavilla Appointed as Chief Executive Officer at Suneva Medical

Company Advances into Next Phase of Regenerative Aesthetics with Industry Veteran

SAN DIEGO, California—Suneva® Medical, Inc., privately held aesthetics company, announces Chief Executive Officer, Patricia…  

Mar 05 2019

Mayo Clinic Study Reports 47% Reduction in C.diff Infection Rates Using Pulsed Xenon UV Room Disinfection

SAN ANTONIO, Texas—Clostridioides difficile (C.diff) is a serious and highly contagious intestinal infection that can cause diarrhea, colitis and even death. Even with the world’s…  

Feb 20 2019

Vestar-backed Healthgrades Buys Influence Health

Healthgrades, a Vestar Capital Partners portfolio company, said Jan. 8 that it acquired Influence Health. Financial terms weren’t announced. Influence Health, of Birmingham, Alabama, provides…  

Jan 08 2019

Gurnet Point Capital Completes Tender Offer for Corium International, Transaction Valued in Excess of $500 Million

CAMBRIDGE, Mass.—(BUSINESS WIRE)—Gurnet Point Capital (“Gurnet Point”), a private investment firm focused on the healthcare and life sciences sectors, announced today that it has completed…  

Nov 27 2018

Axogen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day

Updates Value of the Market Opportunity in Existing Applications from $2.2 Billion to $2.7 Billion

Announces Market Development and Clinical Initiatives for Expanded Application in…  

Nov 19 2018

Avance Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation

RMAT Designation reinforces clinical significance of RANGER® registry data and acknowledges the unmet need for improved nerve repair solutions


Oct 29 2018

EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg

The first long-lasting, FDA approved micro-insert for up to three years of continuous control in chronic, non-infectious posterior segment uveitis, the third leading cause of…  

Oct 15 2018

Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares

Total Transaction Valued in Excess of $500 Million, Representing a 50% Premium

Gurnet Point Capital to Expand Operations While Focusing on the Approval and Commercialization…  

Oct 11 2018

View Legacy Fund news >